The Centre has advised all states and union territories to review their preparedness for prevention and control of fungal infections as well as hygiene and sanitation in hospitals amid surging cases of mucormycosis.
Commonly known as black fungus, some states and UTs have reported an increasing number of patients suffering from mucormycosis in recent days.
Track this LIVE blog for latest updates on coronavirus pandemic
Union Health Secretary Rajesh Bhushan on May 21 wrote to Chief Secretaries and Administrators of all states and UTs, urging them to undertake activities/practices to ensure that there are robust infection prevention and control practices in COVID-19 hospitals and other healthcare facilities.
Bhushan advised them to establish and activate the Hospital Infection Control Committee with the head of the institution or an administrator as the chairperson, designate an infection prevention and control nodal officer -- preferably a microbiologist or senior infection control nurse.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
Read: Provide free treatment for mucormycosis, Congress chief Sonia Gandhi tells PM Narendra Modi
He also asked them to prepare and implement the Infection Prevention Control (IPC) Programme in the hospital/health facilities, as per the guidance given in National Guidelines for Infection and Control in Healthcare Facilities.
Transmission-based precautions need heightened focus on the droplet, airborne and contact precautions from the perspective of protecting healthcare workers and ensuring patient safety, he said in the letter.
Also read: India faces antifungal drug shortage as Black Fungus cases add to COVID-19 woes
Besides, the letter stressed improving the environment and facilitate ventilation with a focus on fresh air and natural ventilation wherever control systems with requisite air changes are not available, cleaning, disinfection and sanitation of the hospital environment and frequently touched surfaces, with recommended disinfectants like 1% sodium hypochlorite or 70% alcohol and safe water and food to prevent water or foodborne diseases in hospital settings.
The letter stated that biomedical waste needs to be managed as per the CPCB guidelines available and that Infection Prevention and Control practices need to be enhanced in Intensive Care Units (ICUs) using a bundle approach to prevent device-associated infections such as ventilator-associated pneumonia or catheter-associated bloodstream, urinary infections etc.
Also read: Govt to import 6.8 lakh vials of Amphotericin-B injections in May, June; domestic production ramped up to 2.6 lakh vials
Infection prevention and control practise in the clinical laboratories and those attached to hospitals are very crucial for the safety of laboratory/hospital staff and health security of the community, the letter stated.
Meticulous adherence to infection prevention and control while managing immunocompromised patients such as COVID-19 patients on steroid treatment, with co-morbidities (such as diabetes where good glycemic control needs to be established), the letter underlined.
(With inputs from PTI)
Click here for Moneycontrol's full coverage of the COVID-19 pandemic